Table 3.

Neutralizing antibody titers present in serum 24 h after treatment with a 1:10 dilution of immune serum.

		Log10 PRNT50a (survival-y/nb)
	Treatment	1:10 MVA-BN YF	1:10 YF-VAX	1:10 Placebo
Animal number	1	1.3 (y)	1.0 (y)	<1.0 (n)
	2	1.0 (y)	1.3 (n)	1.0 (n)
	3	1.0 (n)	1.0 (n)	<1.0 (n)
	4	1.3 (y)	1.0 (n)	<1.0 (n)
	5	1.0 (n)	1.0 (n)	<1.0 (n)
	6	1.3 (y)	1.0 (n)	<1.0 (n)
	7	1.0 (y)	1.0 (n)	<1.0 (y)
	8	1.0 (y)	<1.0 (y)	<1.0 (n)
	9	1.0 (y)	1.0 (y)	<1.0 (n)
	10	1.3 (y)	1.0 (n)	<1.0 (n)
	11			<1.0 (n)
	12			1.0 (n)
	13			1.0 (n)
	14			1.0 (n)
	15			<1.0 (n)

The eventual survival (y) or mortality (n) through 21 dpi is indicated in parentheses.

^aThe log₁₀ 50% of control.

^bDid the animal survive (yes or no)?